1
|
Li Q, Zhang X, Yang X, Pan N, He M, Suo X, Li X, Gong Q, Wang S. Pre-COVID resting-state brain activity in the fusiform gyrus prospectively predicts social anxiety alterations during the pandemic. J Affect Disord 2024; 344:380-388. [PMID: 37838273 DOI: 10.1016/j.jad.2023.10.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/03/2023] [Revised: 09/24/2023] [Accepted: 10/09/2023] [Indexed: 10/16/2023]
Abstract
BACKGROUND Social anxiety (SA) has been linked to the coronavirus disease 2019 (COVID-19) pandemic, but the neurobiopsychological mechanisms underlying this relationship remain unclear. This study aimed to elucidate the neurofunctional markers for COVID-induced SA development and the potential role of COVID-related posttraumatic stress symptoms (PTSS) in the brain-SA alterations link. METHODS Before the COVID-19 pandemic (T1), 100 general college students underwent resting-state magnetic resonance imaging and behavioral tests. During the period of community-level outbreaks (T2), these students were re-contacted to undergo follow-up behavioral assessments. RESULTS Whole-brain correlation and prediction analyses found that pre-pandemic spontaneous neural activity (measured by fractional amplitude of low-frequency fluctuations) in the right fusiform gyrus (FG) was positively correlated to SA alterations (T2 - T1). Mediation analyses revealed that COVID-specific PTSS mediated the effects of right FG on SA alterations. LIMITATIONS The results should be interpreted carefully because only one-session neuroimaging data in a sample of normal adults were included. CONCLUSIONS The results provide evidence for neurofunctional markers of COVID-induced SA and may help develop targeted brain-based interventions that reduce SA.
Collapse
Affiliation(s)
- Qingyuan Li
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Xun Zhang
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China
| | - Xun Yang
- School of Public Affairs, Chongqing University, Chongqing, China
| | - Nanfang Pan
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China
| | - Min He
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China
| | - Xueling Suo
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China
| | - Xiao Li
- Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Qiyong Gong
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China; Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, China.
| | - Song Wang
- Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China; Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China.
| |
Collapse
|
2
|
Biagianti B, Conelea C, Dabit S, Ross D, Beard KL, Harris E, Shen E, Jordan J, Bernstein GA. A Mobile Application Adjunct to Augment Cognitive-Behavioral Group Therapy for Adolescents with Social Anxiety: Feasibility and Acceptability Results from the Wiring Adolescents with Social Anxiety via Behavioral Interventions Pilot Trial. J Child Adolesc Psychopharmacol 2023; 33:212-224. [PMID: 37471177 PMCID: PMC10458379 DOI: 10.1089/cap.2023.0001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 07/22/2023]
Abstract
Objective: Cognitive-Behavioral Group Therapy (CBGT) is an established treatment for Social Anxiety (SA). However, diagnostic recovery rate is only 20.5% in CBGT, and up to 50% of patients remain symptomatic posttreatment. Using videocalls to deliver digital CBGT (dCBGT) is feasible, cost-effective, and efficacious. Yet, the impact of dCBGT on social functioning remains limited, as dCBGT does not offer opportunities for monitoring cognition and behavior in social situations. Wiring Adolescents with Social Anxiety via Behavioral Interventions (WASABI), a clinician-assisted application that uses ecological momentary assessments (EMAs), cognitive bias tests, and clinical self-reports, was investigated as an adjunct to dCBGT. Methods: A prospective, parallel arm, double-blind randomized controlled trial was employed in 24 SA adolescents randomly assigned to dCBGT versus dCBGT plus WASABI. Results: Study completion rates (83%) and exit survey data indicated that WASABI is feasible and acceptable. Engagement with EMAs varied from four to 244 EMAs completed per person. Cognitive bias tests and clinical self-reports were completed at least weekly by 53% and 69% of participants, respectively. While standard tests did not reveal statistically significant differences between dCBGT plus WASABI and dCBGT alone, effect sizes were greater for dCBGT plus WASABI on symptom severity, social skills, and functioning. Conclusions: Despite the small sample, preliminary results suggest that WASABI is feasible, acceptable, and may be an effective augmentation tool for treating SA in teenagers.
Collapse
Affiliation(s)
- Bruno Biagianti
- Department of Psychology, University of Milano-Bicocca, Milan, Italy
| | - Christine Conelea
- Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Masonic Institute for the Developing Brain, Minneapolis, Minnesota, USA
| | - Sawsan Dabit
- Department of R&D, Posit Science Corporation, San Francisco, California, USA
| | - Daniel Ross
- Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Masonic Institute for the Developing Brain, Minneapolis, Minnesota, USA
| | - Katie L. Beard
- Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Masonic Institute for the Developing Brain, Minneapolis, Minnesota, USA
| | - Elizabeth Harris
- Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Masonic Institute for the Developing Brain, Minneapolis, Minnesota, USA
| | - Erin Shen
- Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Masonic Institute for the Developing Brain, Minneapolis, Minnesota, USA
| | - Josh Jordan
- Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA
| | - Gail A. Bernstein
- Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Masonic Institute for the Developing Brain, Minneapolis, Minnesota, USA
| |
Collapse
|
3
|
Positive valence systems in youth anxiety development: A scoping review. J Anxiety Disord 2022; 89:102588. [PMID: 35691120 DOI: 10.1016/j.janxdis.2022.102588] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Revised: 05/23/2022] [Accepted: 05/27/2022] [Indexed: 10/18/2022]
Abstract
Research on pathophysiological mechanisms supporting anxiety development in youth has traditionally focused on the role of threat systems. However, emerging research suggests that the positive valence system (PVS) may also play a strong and unique role in the development and maintenance of anxiety during childhood and adolescence. To better understand the connection between the PVS and anxiety, this scoping review describes current research spanning multiple units of analysis (i.e., self-report, behavior, neural circuits) linking child and adolescent anxiety and risk for anxiety to various PVS constructs (i.e., positive affect, reward responsiveness, reward learning and decision-making). After screening, 78 peer-reviewed articles and dissertations published between 1998 and May 2021 were included in a qualitative review. Though some consistencies in the literature were found, such as high neural reactivity to incentive anticipation in youth at temperamental risk for social anxiety and blunted positive affect in youth with social anxiety disorder, the literature is largely inconsistent. Inconsistencies could be related to the small number of similar studies, small and homogenous study samples, and variability in methodologies employed in this research. It cannot be confirmed whether findings linking PVS constructs to anxiety are unique to anxiety symptoms or better accounted for by co-occurring depressive symptoms. This review concludes with recommendations for robust future research in this area.
Collapse
|
4
|
Abstract
Social anxiety disorder (SAD) is a common psychiatric disorder, often associated with avoidant temperament. Research studies have implicated a strong genetic architecture of SAD. We have conducted a systematic review on the genetics of SAD and yielded 66 articles. In general, prior research studies have focused on the serotonin transporter, oxytocin receptor, brain-derived neurotrophic factor and catechol-O-methyltransferase genes. Mixed and inconsistent results have been reported. Additional approaches and phenotypes have also been investigated, including pharmacogenetics of treatment response, imaging genetics and gene-environment interactions. Future directions warrant further international collaborative efforts, deep-phenotyping of clinical characteristics including consistent and reliable measurement-based symptom severity, and larger sample sizes to ensure sufficient power for stratification due to the heterogeneity of this chronic and often debilitating condition.
Collapse
Affiliation(s)
- Ami Baba
- Neurogenetics Section, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre
| | - Stefan Kloiber
- Campbell Family Mental Health Research Institute, General Adult Psychiatry and Health Systems Division, Centre for Addiction and Mental Health
- Department of Psychiatry, University of Toronto
- Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Gwyneth Zai
- Neurogenetics Section, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre
- Campbell Family Mental Health Research Institute, General Adult Psychiatry and Health Systems Division, Centre for Addiction and Mental Health
- Department of Psychiatry, University of Toronto
- Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
5
|
Bas‐Hoogendam JM, Groenewold NA, Aghajani M, Freitag GF, Harrewijn A, Hilbert K, Jahanshad N, Thomopoulos SI, Thompson PM, Veltman DJ, Winkler AM, Lueken U, Pine DS, Wee NJA, Stein DJ, Agosta F, Åhs F, An I, Alberton BAV, Andreescu C, Asami T, Assaf M, Avery SN, Nicholas L, Balderston, Barber JP, Battaglia M, Bayram A, Beesdo‐Baum K, Benedetti F, Berta R, Björkstrand J, Blackford JU, Blair JR, Karina S, Blair, Boehme S, Brambilla P, Burkhouse K, Cano M, Canu E, Cardinale EM, Cardoner N, Clauss JA, Cividini C, Critchley HD, Udo, Dannlowski, Deckert J, Demiralp T, Diefenbach GJ, Domschke K, Doruyter A, Dresler T, Erhardt A, Fallgatter AJ, Fañanás L, Brandee, Feola, Filippi CA, Filippi M, Fonzo GA, Forbes EE, Fox NA, Fredrikson M, Furmark T, Ge T, Gerber AJ, Gosnell SN, Grabe HJ, Grotegerd D, Gur RE, Gur RC, Harmer CJ, Harper J, Heeren A, Hettema J, Hofmann D, Hofmann SG, Jackowski AP, Andreas, Jansen, Kaczkurkin AN, Kingsley E, Kircher T, Kosti c M, Kreifelts B, Krug A, Larsen B, Lee S, Leehr EJ, Leibenluft E, Lochner C, Maggioni E, Makovac E, Mancini M, Manfro GG, Månsson KNT, Meeten F, Michałowski J, Milrod BL, Mühlberger A, Lilianne R, Mujica‐Parodi, Munjiza A, Mwangi B, Myers M, Igor Nenadi C, Neufang S, Nielsen JA, Oh H, Ottaviani C, Pan PM, Pantazatos SP, Martin P, Paulus, Perez‐Edgar K, Peñate W, Perino MT, Peterburs J, Pfleiderer B, Phan KL, Poletti S, Porta‐Casteràs D, Price RB, Pujol J, Andrea, Reinecke, Rivero F, Roelofs K, Rosso I, Saemann P, Salas R, Salum GA, Satterthwaite TD, Schneier F, Schruers KRJ, Schulz SM, Schwarzmeier H, Seeger FR, Smoller JW, Soares JC, Stark R, Stein MB, Straube B, Straube T, Strawn JR, Suarez‐Jimenez B, Boris, Suchan, Sylvester CM, Talati A, Tamburo E, Tükel R, Heuvel OA, Van der Auwera S, Nieuwenhuizen H, Tol M, van Velzen LS, Bort CV, Vermeiren RRJM, Visser RM, Volman I, Wannemüller A, Wendt J, Werwath KE, Westenberg PM, Wiemer J, Katharina, Wittfeld, Wu M, Yang Y, Zilverstand A, Zugman A, Zwiebel HL. ENIGMA-anxiety working group: Rationale for and organization of large-scale neuroimaging studies of anxiety disorders. Hum Brain Mapp 2022; 43:83-112. [PMID: 32618421 PMCID: PMC8805695 DOI: 10.1002/hbm.25100] [Citation(s) in RCA: 29] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2020] [Revised: 05/09/2020] [Accepted: 06/08/2020] [Indexed: 12/11/2022] Open
Abstract
Anxiety disorders are highly prevalent and disabling but seem particularly tractable to investigation with translational neuroscience methodologies. Neuroimaging has informed our understanding of the neurobiology of anxiety disorders, but research has been limited by small sample sizes and low statistical power, as well as heterogenous imaging methodology. The ENIGMA-Anxiety Working Group has brought together researchers from around the world, in a harmonized and coordinated effort to address these challenges and generate more robust and reproducible findings. This paper elaborates on the concepts and methods informing the work of the working group to date, and describes the initial approach of the four subgroups studying generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobia. At present, the ENIGMA-Anxiety database contains information about more than 100 unique samples, from 16 countries and 59 institutes. Future directions include examining additional imaging modalities, integrating imaging and genetic data, and collaborating with other ENIGMA working groups. The ENIGMA consortium creates synergy at the intersection of global mental health and clinical neuroscience, and the ENIGMA-Anxiety Working Group extends the promise of this approach to neuroimaging research on anxiety disorders.
Collapse
Affiliation(s)
- Janna Marie Bas‐Hoogendam
- Department of Developmental and Educational PsychologyLeiden University, Institute of Psychology Leiden The Netherlands
- Department of PsychiatryLeiden University Medical Center Leiden The Netherlands
- Leiden Institute for Brain and Cognition Leiden The Netherlands
| | - Nynke A. Groenewold
- Department of Psychiatry & Mental HealthUniversity of Cape Town Cape Town South Africa
| | - Moji Aghajani
- Department of PsychiatryAmsterdam UMC / VUMC Amsterdam The Netherlands
- Department of Research & InnovationGGZ inGeest Amsterdam The Netherlands
| | - Gabrielle F. Freitag
- National Institute of Mental Health, Emotion and Development Branch Bethesda Maryland USA
| | - Anita Harrewijn
- National Institute of Mental Health, Emotion and Development Branch Bethesda Maryland USA
| | - Kevin Hilbert
- Department of PsychologyHumboldt‐Universität zu Berlin Berlin Germany
| | - Neda Jahanshad
- University of Southern California Keck School of MedicineImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute Los Angeles California USA
| | - Sophia I. Thomopoulos
- University of Southern California Keck School of MedicineImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute Los Angeles California USA
| | - Paul M. Thompson
- University of Southern California Keck School of MedicineImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute Los Angeles California USA
| | - Dick J. Veltman
- Department of PsychiatryAmsterdam UMC / VUMC Amsterdam The Netherlands
| | - Anderson M. Winkler
- National Institute of Mental Health, Emotion and Development Branch Bethesda Maryland USA
| | - Ulrike Lueken
- Department of PsychologyHumboldt‐Universität zu Berlin Berlin Germany
| | - Daniel S. Pine
- National Institute of Mental Health, Emotion and Development Branch Bethesda Maryland USA
| | - Nic J. A. Wee
- Department of PsychiatryLeiden University Medical Center Leiden The Netherlands
- Leiden Institute for Brain and Cognition Leiden The Netherlands
| | - Dan J. Stein
- Department of Psychiatry & Mental HealthUniversity of Cape Town Cape Town South Africa
- University of Cape TownSouth African MRC Unit on Risk & Resilience in Mental Disorders Cape Town South Africa
- University of Cape TownNeuroscience Institute Cape Town South Africa
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Bas-Hoogendam JM, Westenberg PM. Imaging the socially-anxious brain: recent advances and future prospects. F1000Res 2020; 9:F1000 Faculty Rev-230. [PMID: 32269760 PMCID: PMC7122428 DOI: 10.12688/f1000research.21214.1] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 03/23/2020] [Indexed: 12/20/2022] Open
Abstract
Social anxiety disorder (SAD) is serious psychiatric condition with a genetic background. Insight into the neurobiological alterations underlying the disorder is essential to develop effective interventions that could relieve SAD-related suffering. In this expert review, we consider recent neuroimaging work on SAD. First, we focus on new results from magnetic resonance imaging studies dedicated to outlining biomarkers of SAD, including encouraging findings with respect to structural and functional brain alterations associated with the disorder. Furthermore, we highlight innovative studies in the field of neuroprediction and studies that established the effects of treatment on brain characteristics. Next, we describe novel work aimed to delineate endophenotypes of SAD, providing insight into the genetic susceptibility to develop the disorder. Finally, we outline outstanding questions and point out directions for future research.
Collapse
Affiliation(s)
- Janna Marie Bas-Hoogendam
- Developmental and Educational Psychology, Institute of Psychology, Leiden University, Wassenaarseweg 52, 2333 AK Leiden, The Netherlands
- Leiden Institute for Brain and Cognition, c/o LUMC, postzone C2-S, P.O.Box 9600, 2300 RC Leiden, The Netherlands
- Department of Psychiatry, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
| | - P. Michiel Westenberg
- Developmental and Educational Psychology, Institute of Psychology, Leiden University, Wassenaarseweg 52, 2333 AK Leiden, The Netherlands
- Leiden Institute for Brain and Cognition, c/o LUMC, postzone C2-S, P.O.Box 9600, 2300 RC Leiden, The Netherlands
| |
Collapse
|
7
|
Khan WU, Michelini G, Battaglia M. Twin studies of the covariation of pain with depression and anxiety: A systematic review and re-evaluation of critical needs. Neurosci Biobehav Rev 2020; 111:135-148. [DOI: 10.1016/j.neubiorev.2020.01.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2019] [Revised: 12/13/2019] [Accepted: 01/15/2020] [Indexed: 01/21/2023]
|
8
|
Wang M, Tian X, Zhang W. Interactions between the combined genotypes of 5-HTTLPR and BDNF Val66Met polymorphisms and parenting on adolescent depressive symptoms: A three-year longitudinal study. J Affect Disord 2020; 265:104-111. [PMID: 32090731 DOI: 10.1016/j.jad.2020.01.064] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 01/09/2020] [Accepted: 01/14/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND The importance of multiple genes-environment interaction (G × E) has been highlighted in studies on depressive symptoms. 5-HTTLPR and BDNF Val66Met polymorphisms, with functional interconnection, have been implicated in the pathophysiology of depressive symptoms. However, little is understood about whether the interaction of 5-HTTLPR, BDNF Val66Met and parenting fits better with the epistatic or cumulative manner. METHODS 865 adolescents (T1: Mage = 12.32, 50.2% girls) were included in a three-year interval longitudinal design. Standardized questionares about parenting and depressive symptoms were collected. Saliva samples were collected for genotyping. RESULTS Neither the concurrent nor longitudinal interaction of 5-HTTLPR, BDNF Val66Met and parenting (G × G × E) showed significant effects on depressive symptoms. The interaction between cumulative genotypes and positive parenting (CG × E) was significant, with the strong differential susceptibility model, for depressive symptoms concurrently but not longitudinally after statistical correction. Adolescents who carried 3 (i.e. SS and Val/Met, L allele and Val/Val) and 4 (i.e. SS and Val/Val), not 1 (i.e. L allele and Met/Met) or 2 cumulative susceptibility alleles (i.e. SS and Met/Met, L allele and Val/Met), reported fewer depressive symptoms if they had experienced higher levels of positive parenting, and more symptoms under lower levels of positive parenting. LIMITATIONS This study did not examine the 5-HTTLPR triallelic (rs25531) marker and did not include an external sample. CONCLUSIONS The combined effects of 5-HTTLPR and BDNF Val66Met polymorphisms functioned in a manner of cumulative rather than epistatic in response to positive parenting on early adolescent depressive symptoms.
Collapse
Affiliation(s)
- Meiping Wang
- Department of Psychology, Shandong Normal University, Jinan 250014, Shandong Province, China
| | - Xiangjuan Tian
- Department of Psychology, Shandong Normal University, Jinan 250014, Shandong Province, China
| | - Wenxin Zhang
- Department of Psychology, Shandong Normal University, Jinan 250014, Shandong Province, China.
| |
Collapse
|
9
|
Biagianti B, Conelea C, Brambilla P, Bernstein G. A systematic review of treatments targeting cognitive biases in socially anxious adolescents: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. J Affect Disord 2020; 264:543-551. [PMID: 32056778 PMCID: PMC7024067 DOI: 10.1016/j.jad.2019.12.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 11/13/2019] [Accepted: 12/02/2019] [Indexed: 12/30/2022]
Abstract
BACKGROUND Adolescence is a period of brain plasticity that is affected by social and affective stimuli. Adaptive neurodevelopmental changes in the context of complex social situations may precipitate or exacerbate cognitive biases (i.e., attention and/or interpretation biases) and predispose at-risk individuals to symptoms of social anxiety. METHODS This systematic review followed the PRISMA guidelines. Nine adolescent studies were examined including 3 studies using Cognitive Bias Modification Training (CBMT) to target attention biases (CBMT-A), 3 studies using CBMT to target interpretation biases (CBMT-I), and 3 aimed at reducing both attention and interpretation biases. RESULTS The studies of CBMT-A alone did not find significant effects on cognitive and clinical outcomes. However, studies of CBMT-I alone showed some improvement in interpretation bias. The combination of CBMT-A and CBMT-I appeared promising in reducing both attentionl and interpretation biases. LIMITATIONS The paucity of studies and the heterogeneity across studies (e.g., format of CBMT, assessment measures) limit the calculation of overall effect sizes and the examination of predictors, moderators, and mediators of outcome. CONCLUSIONS Technology-driven interventions such as CBMT have the potential to extend treatments outside the clinic setting and to augment current therapies for social anxiety. Further research is needed to develop CBMT procedures that optimize learning in group and real-world settings and to identify predictors of treatment response. Understanding the neural correlates of response to CBMT may help identify future targets for intervention.
Collapse
Affiliation(s)
- Bruno Biagianti
- Department of R&D, Posit Science Corporation, San Francisco, CA, USA; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
| | - Christine Conelea
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA
| | - Paolo Brambilla
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy,Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Gail Bernstein
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA
| |
Collapse
|
10
|
Zdebik MA, Boivin M, Battaglia M, Tremblay RE, Falissard B, Côté SM. Childhood multi-trajectories of shyness, anxiety and depression: Associations with adolescent internalizing problems. JOURNAL OF APPLIED DEVELOPMENTAL PSYCHOLOGY 2019. [DOI: 10.1016/j.appdev.2019.101050] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Balada F, Lucas I, Blanch Á, Blanco E, Aluja A. Neuroticism is associated with reduced oxygenation levels in the lateral prefrontal cortex following exposure to unpleasant images. Physiol Behav 2019; 199:66-72. [DOI: 10.1016/j.physbeh.2018.11.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Revised: 10/04/2018] [Accepted: 11/02/2018] [Indexed: 12/22/2022]
|
12
|
Palmieri S, Mansueto G, Scaini S, Fiore F, Sassaroli S, Ruggiero GM, Borlimi R, Carducci BJ. Role of rumination in the relationship between metacognition and shyness. World J Psychiatry 2018; 8:108-113. [PMID: 30370229 PMCID: PMC6201322 DOI: 10.5498/wjp.v8.i4.108] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2018] [Revised: 08/06/2018] [Accepted: 08/21/2018] [Indexed: 02/05/2023] Open
Abstract
AIM To explore the association between metacognitive beliefs, rumination and shyness in a non-clinical sample of adults.
METHODS One hundred and three healthy subjects from the general population were enrolled in the study. Shyness was evaluated using the Revised Cheek and Buss Shyness Scale, rumination was assessed using the Ruminative Response Scale, metacognition was evaluated using the Meta-Cognitions Questionnaire 30, and anxiety levels were measured using the State Trait Anxiety Inventory form Y. Correlation analyses, mediation models and 95% bias-corrected and accelerated (BCaCI) bootstrapped analyses were performed. Mediation analyses were adjusted for sex and anxiety.
RESULTS Shyness, rumination and metacognition were significantly correlated (P < 0.05). The relationship between metacognition and shyness was fully mediated by rumination (Indirect effect: 0.20; 95% BCaCI: 0.08-0.33).
CONCLUSION These findings suggest an association between metacognition and shyness. Rumination mediated the relationship between metacognition and shyness, suggesting that rumination could be a cognitive strategy for shy people. Future research should explore the relationship between these constructs in more depth.
Collapse
Affiliation(s)
- Sara Palmieri
- Studi Cognitivi, Cognitive Psychotherapy School and Research Center, Milan 20121, Italy
- Department of Psychology, Sigmund Freud University, Milan 20143, Italy
| | - Giovanni Mansueto
- Studi Cognitivi, Cognitive Psychotherapy School and Research Center, Milan 20121, Italy
- Department of Psychology, Sigmund Freud University, Milan 20143, Italy
| | - Simona Scaini
- Department of Psychology, Sigmund Freud University, Milan 20143, Italy
| | - Francesca Fiore
- Studi Cognitivi, Cognitive Psychotherapy School and Research Center, Milan 20121, Italy
| | - Sandra Sassaroli
- Studi Cognitivi, Cognitive Psychotherapy School and Research Center, Milan 20121, Italy
- Department of Psychology, Sigmund Freud University, Milan 20143, Italy
| | - Giovanni M Ruggiero
- Department of Psychology, Sigmund Freud University, Milan 20143, Italy
- Psicoterapia Cognitiva e Ricerca, Cognitive Psychotherapy School, Milan 20121, Italy
| | - Rosita Borlimi
- Department of Psychology, Sigmund Freud University, Milan 20143, Italy
| | - Bernardo J Carducci
- Shyness Research Institute, Indiana University Southeast, New Albany, OH 47150, United States
| |
Collapse
|
13
|
Haller SPW, Mills KL, Hartwright CE, David AS, Cohen Kadosh K. When change is the only constant: The promise of longitudinal neuroimaging in understanding social anxiety disorder. Dev Cogn Neurosci 2018; 33:73-82. [PMID: 29960860 PMCID: PMC6969264 DOI: 10.1016/j.dcn.2018.05.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2017] [Revised: 05/21/2018] [Accepted: 05/23/2018] [Indexed: 12/27/2022] Open
Abstract
Longitudinal studies offer a unique window into developmental change. Yet, most of what we know about the pathophysiology of psychiatric disorders is based on cross-sectional work. Here, we highlight the importance of adopting a longitudinal approach in order to make progress towards identifying the neurobiological mechanisms of social anxiety disorder (SAD). Using examples, we illustrate how longitudinal data can uniquely inform SAD etiology and timing of interventions. The brain's inherently adaptive quality requires that we model risk correlates of disorders as dynamic in their expression. Developmental theories regarding timing of environmental events, cascading effects and (mal)adaptations of the developing brain will be crucial components of comprehensive, integrative models of SAD. We close by discussing analytical considerations when working with longitudinal, developmental data.
Collapse
Affiliation(s)
| | | | - Charlotte E Hartwright
- Department of Experimental Psychology, University of Oxford, UK; Aston Brain Center, Aston University, UK
| | - Anthony S David
- Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK
| | - Kathrin Cohen Kadosh
- Department of Experimental Psychology, University of Oxford, UK; School of Psychology, University of Surrey, UK.
| |
Collapse
|
14
|
Rosen ML, Sheridan MA, Sambrook KA, Dennison MJ, Jenness JL, Askren MK, Meltzoff AN, McLaughlin KA. Salience network response to changes in emotional expressions of others is heightened during early adolescence: relevance for social functioning. Dev Sci 2018; 21:e12571. [PMID: 28557315 PMCID: PMC5709230 DOI: 10.1111/desc.12571] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Accepted: 03/10/2017] [Indexed: 11/27/2022]
Abstract
Adolescence is a unique developmental period when the salience of social and emotional information becomes particularly pronounced. Although this increased sensitivity to social and emotional information has frequently been considered with respect to risk behaviors and psychopathology, evidence suggests that increased adolescent sensitivity to social and emotional cues may confer advantages. For example, greater sensitivity to shifts in the emotions of others is likely to promote flexible and adaptive social behavior. In this study, a sample of 54 children and adolescents (age 8-19 years) performed a delayed match-to-sample task for emotional faces while undergoing fMRI scanning. Recruitment of the anterior cingulate and anterior insula when the emotion of the probe face did not match the emotion held in memory followed a quadratic developmental pattern that peaked during early adolescence. These findings indicate meaningful developmental variation in the neural mechanisms underlying sensitivity to changes in the emotional expressions. Across all participants, greater activation of this network for changes in emotional expression was associated with less social anxiety and fewer social problems. These results suggest that the heightened salience of social and emotional information during adolescence may confer important advantages for social behavior, providing sensitivity to others' emotions that facilitates flexible social responding.
Collapse
Affiliation(s)
- Maya L. Rosen
- Department of Psychology, University of Washington, Seattle, WA, USA
| | | | | | - Meg J. Dennison
- Department of Psychology, University of Washington, Seattle, WA, USA
| | | | - Mary K. Askren
- Department of Psychology, University of Washington, Seattle, WA, USA
| | | | | |
Collapse
|
15
|
Jiang JH, Peng YL, Zhang PJ, Xue HX, He Z, Liang XY, Chang M. The ventromedial hypothalamic nucleus plays an important role in anxiolytic-like effect of neuropeptide S. Neuropeptides 2018; 67:36-44. [PMID: 29195839 DOI: 10.1016/j.npep.2017.11.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/13/2017] [Revised: 11/06/2017] [Accepted: 11/06/2017] [Indexed: 02/08/2023]
Abstract
Neuropeptide S (NPS), the endogenous neuropeptide ligand of NPSR, has been reported to regulate anxiety-related behavior involved in multiple brain regions, including amygdale, locus coeruleus and Barrington's nucleus. However, little research has been conducted on the anxiolytic-like behaviors of NPS on the hypothalamus, which was an important area in defensive behavior. Here, we investigated a role of hypothalamus in anxiolytic-like behaviors of NPS. We found that NPSR protein of mouse distributed mainly in the ventromedial hypothalamus (VMH). And in the single prolonged stress model (SPS), the results showed that NPS mRNA of the mice exposed to SPS was significantly higher than control, while NPSR mRNA was remarkable lower than control in hypothalamus. Further studies found that NPS intra-VMH infusion dose-dependently (1, 10 and 100pmol) induced anxiolytic effects, using elevated plus maze and open field tests. These anxiolytic effects could be blocked by NPSR antagonist (SHA68), but not by picrotoxin (a GABAA receptor antagonist) and sacolfen (a GABAB receptor antagonist). Meanwhile, our data showed that the expression of c-Fos was significantly increased in VMH after NPS delivered into the lateral ventricles. These results cast a new light on the hypothalamic nucleus in the anxiolytic-like effect of NPS system.
Collapse
Affiliation(s)
- Jin Hong Jiang
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China
| | - Ya Li Peng
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China
| | - Pei Jiang Zhang
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China
| | - Hong Xiang Xue
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China
| | - Zhen He
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China
| | - Xue Ya Liang
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China
| | - M Chang
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Lanzhou University, Lanzhou 730000, China.
| |
Collapse
|
16
|
Battaglia M, Khan WU. Reappraising Preclinical Models of Separation Anxiety Disorder, Panic Disorder, and CO 2 Sensitivity: Implications for Methodology and Translation into New Treatments. Curr Top Behav Neurosci 2018; 40:195-217. [PMID: 29696603 DOI: 10.1007/7854_2018_42] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Separation anxiety applies to multiple forms of distress responses seen in mammals during postnatal development, including separation from a caregiver. Childhood separation anxiety disorder is an important risk factor for developing panic disorder in early adulthood, and both conditions display an increased sensitivity to elevated CO2 concentrations inhaled from the air. By interfacing epidemiological, genetic, and physiological knowledge with preclinical animal research models, it is possible to decipher the mechanisms that are central to separation anxiety and panic disorders while also suggesting possible therapies. Preclinical research models allow for environmentally controlled studies of early interferences with parental care. These models have shown that different forms of early maternal separation in mice and rats induce elevated CO2 respiratory sensitivity, an important biomarker of separation anxiety and panic disorders. In mice, this is likely due to gene-environment interactions that affect multiple behavioural and physical phenotypes after exposure to this early adversity. Although several questions regarding the causal mechanism of separation anxiety and panic disorder remain unanswered, the identification and improved understanding of biomarkers that link these mental health conditions under the guise of preclinical research models in conjunction with human longitudinal cohort studies can help resolve these issues.
Collapse
Affiliation(s)
- Marco Battaglia
- Division of Child, Youth and Emerging Adulthood Psychiatry, Centre for Addiction & Mental Health, Toronto, ON, Canada.
- Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
| | - Waqas Ullah Khan
- Division of Child, Youth and Emerging Adulthood Psychiatry, Centre for Addiction & Mental Health, Toronto, ON, Canada
- School of Medicine, Faculty of Health Sciences, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
17
|
Klein M, van Donkelaar M, Verhoef E, Franke B. Imaging genetics in neurodevelopmental psychopathology. Am J Med Genet B Neuropsychiatr Genet 2017; 174:485-537. [PMID: 29984470 PMCID: PMC7170264 DOI: 10.1002/ajmg.b.32542] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/26/2016] [Revised: 02/02/2017] [Accepted: 03/10/2017] [Indexed: 01/27/2023]
Abstract
Neurodevelopmental disorders are defined by highly heritable problems during development and brain growth. Attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorders (ASDs), and intellectual disability (ID) are frequent neurodevelopmental disorders, with common comorbidity among them. Imaging genetics studies on the role of disease-linked genetic variants on brain structure and function have been performed to unravel the etiology of these disorders. Here, we reviewed imaging genetics literature on these disorders attempting to understand the mechanisms of individual disorders and their clinical overlap. For ADHD and ASD, we selected replicated candidate genes implicated through common genetic variants. For ID, which is mainly caused by rare variants, we included genes for relatively frequent forms of ID occurring comorbid with ADHD or ASD. We reviewed case-control studies and studies of risk variants in healthy individuals. Imaging genetics studies for ADHD were retrieved for SLC6A3/DAT1, DRD2, DRD4, NOS1, and SLC6A4/5HTT. For ASD, studies on CNTNAP2, MET, OXTR, and SLC6A4/5HTT were found. For ID, we reviewed the genes FMR1, TSC1 and TSC2, NF1, and MECP2. Alterations in brain volume, activity, and connectivity were observed. Several findings were consistent across studies, implicating, for example, SLC6A4/5HTT in brain activation and functional connectivity related to emotion regulation. However, many studies had small sample sizes, and hypothesis-based, brain region-specific studies were common. Results from available studies confirm that imaging genetics can provide insight into the link between genes, disease-related behavior, and the brain. However, the field is still in its early stages, and conclusions about shared mechanisms cannot yet be drawn.
Collapse
Affiliation(s)
- Marieke Klein
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands
| | - Marjolein van Donkelaar
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands
| | - Ellen Verhoef
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands
| | - Barbara Franke
- Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands
- Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands
| |
Collapse
|
18
|
Battaglia M, Michelini G, Pezzica E, Ogliari A, Fagnani C, Stazi MA, Bertoletti E, Scaini S. Shared genetic influences among childhood shyness, social competences, and cortical responses to emotions. J Exp Child Psychol 2017; 160:67-80. [PMID: 28432866 DOI: 10.1016/j.jecp.2017.03.012] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Revised: 03/15/2017] [Accepted: 03/19/2017] [Indexed: 01/13/2023]
Abstract
Visual event-related potentials (ERPs) evoked by facial expressions are useful to map socioemotional responses among shy children and to predict transition into social phobia. We investigated the sources of covariation among childhood shyness, social competences, and ERPs to other children's happy, neutral, and angry expressions. Electrophysiological and twin analyses examined the phenotypic and etiological association among an index of childhood shyness, an index of social competences, and ERP responses to facial expressions in 200 twins (mean age=9.23years). Multivariate twin analyses showed that the covariation among shyness, social competences, and a composite of a frontal late negative component occurring around 200-400ms in response to happy, neutral, and angry expressions could be entirely explained by shared genetic factors. A coherent causal structure links childhood shyness, social competences, and the cortical responses to facial emotions. A common genetic substrate can explain the interrelatedness of individual differences for childhood shyness, social competences, and some associated electrophysiological responses to socioemotional signals.
Collapse
Affiliation(s)
- Marco Battaglia
- Department of Psychiatry, University of Toronto, Toronto, Ontario M6J 1H4, Canada; Division of Child and Youth Psychiatry, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario M6J 1H4, Canada.
| | - Giorgia Michelini
- MRC Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8AF, UK
| | - Elettra Pezzica
- Developmental Psychopathology Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy
| | - Anna Ogliari
- Developmental Psychopathology Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy; Department of Clinical Neurosciences, San Raffaele Hospital, 20132 Milan, Italy
| | | | | | - Eleonora Bertoletti
- Department of Clinical Neurosciences, San Raffaele Hospital, 20132 Milan, Italy
| | - Simona Scaini
- Developmental Psychopathology Unit, Vita-Salute San Raffaele University, 20132 Milan, Italy; Faculty of Psychology, Sigmund Freud University, 20143 Milan, Italy
| |
Collapse
|
19
|
Raab K, Kirsch P, Mier D. Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature. Neurosci Biobehav Rev 2016; 71:176-197. [DOI: 10.1016/j.neubiorev.2016.08.031] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2016] [Revised: 07/28/2016] [Accepted: 08/26/2016] [Indexed: 12/22/2022]
|
20
|
Bas-Hoogendam JM, Blackford JU, Brühl AB, Blair KS, van der Wee NJ, Westenberg PM. Neurobiological candidate endophenotypes of social anxiety disorder. Neurosci Biobehav Rev 2016; 71:362-378. [DOI: 10.1016/j.neubiorev.2016.08.040] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 07/15/2016] [Accepted: 08/31/2016] [Indexed: 02/07/2023]
|
21
|
Developmental psychopathology in an era of molecular genetics and neuroimaging: A developmental neurogenetics approach. Dev Psychopathol 2016; 27:587-613. [PMID: 25997774 DOI: 10.1017/s0954579415000188] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The emerging field of neurogenetics seeks to model the complex pathways from gene to brain to behavior. This field has focused on imaging genetics techniques that examine how variability in common genetic polymorphisms predict differences in brain structure and function. These studies are informed by other complimentary techniques (e.g., animal models and multimodal imaging) and have recently begun to incorporate the environment through examination of Imaging Gene × Environment interactions. Though neurogenetics has the potential to inform our understanding of the development of psychopathology, there has been little integration between principles of neurogenetics and developmental psychopathology. The paper describes a neurogenetics and Imaging Gene × Environment approach and how these approaches have been usefully applied to the study of psychopathology. Six tenets of developmental psychopathology (the structure of phenotypes, the importance of exploring mechanisms, the conditional nature of risk, the complexity of multilevel pathways, the role of development, and the importance of who is studied) are identified, and how these principles can further neurogenetics applications to understanding the development of psychopathology is discussed. A major issue of this piece is how neurogenetics and current imaging and molecular genetics approaches can be incorporated into developmental psychopathology perspectives with a goal of providing models for better understanding pathways from among genes, environments, the brain, and behavior.
Collapse
|
22
|
Dynamic changes in amygdala activation and functional connectivity in children and adolescents with anxiety disorders. Dev Psychopathol 2015; 26:1305-19. [PMID: 25422963 DOI: 10.1017/s0954579414001047] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Anxiety disorders are associated with abnormalities in amygdala function and prefrontal cortex-amygdala connectivity. The majority of functional magnetic resonance imaging studies have examined mean group differences in amygdala activation or connectivity in children and adolescents with anxiety disorders relative to controls, but emerging evidence suggests that abnormalities in amygdala function are dependent on the timing of the task and may vary across the course of a scanning session. The goal of the present study was to extend our knowledge of the dynamics of amygdala dysfunction by examining whether changes in amygdala activation and connectivity over scanning differ in pediatric anxiety disorder patients relative to typically developing controls during an emotion processing task. Examining changes in activation over time allows for a comparison of how brain function differs during initial exposure to novel stimuli versus more prolonged exposure. Participants included 34 anxiety disorder patients and 19 controls 7 to 19 years old. Participants performed an emotional face-matching task during functional magnetic resonance imaging scanning, and the task was divided into thirds in order to examine change in activation over time. Results demonstrated that patients exhibited an abnormal pattern of amygdala activation characterized by an initially heightened amygdala response relative to controls at the beginning of scanning, followed by significant decreases in activation over time. In addition, controls evidenced greater context-modulated prefrontal cortex-amygdala connectivity during the beginning of scanning relative to patients. These results indicate that differences in emotion processing between the groups vary from initial exposure to novel stimuli relative to more prolonged exposure. Implications are discussed regarding how this pattern of neural activation may relate to altered early-occurring or anticipatory emotion-regulation strategies and maladaptive later-occurring strategies in children and adolescents with anxiety disorders.
Collapse
|
23
|
Haller SPW, Cohen Kadosh K, Scerif G, Lau JYF. Social anxiety disorder in adolescence: How developmental cognitive neuroscience findings may shape understanding and interventions for psychopathology. Dev Cogn Neurosci 2015; 13:11-20. [PMID: 25818181 PMCID: PMC6989773 DOI: 10.1016/j.dcn.2015.02.002] [Citation(s) in RCA: 68] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2013] [Revised: 02/06/2015] [Accepted: 02/06/2015] [Indexed: 11/26/2022] Open
Abstract
Social anxiety disorder represents a debilitating condition that has large adverse effects on the quality of social connections, educational achievement and wellbeing. Age-of-onset data suggests that early adolescence is a developmentally sensitive juncture for the onset of social anxiety. In this review, we highlight the potential of using a developmental cognitive neuroscience approach to understand (i) why there are normative increases in social worries in adolescence and (ii) how adolescence-associated changes may 'bring out' neuro-cognitive risk factors for social anxiety in a subset of individuals during this developmental period. We also speculate on how changes that occur in learning and plasticity may allow for optimal acquisition of more adaptive neurocognitive strategies through external interventions. Hence, for the minority of individuals who require external interventions to target their social fears, this enhanced flexibility could result in more powerful and longer-lasting therapeutic effects. We will review two novel interventions that target information-processing biases and their neural substrates via cognitive training and visual feedback of neural activity measured through functional magnetic resonance imaging.
Collapse
Affiliation(s)
- Simone P W Haller
- Department of Experimental Psychology, University of Oxford, Oxford, UK.
| | | | - Gaia Scerif
- Department of Experimental Psychology, University of Oxford, Oxford, UK
| | - Jennifer Y F Lau
- Department of Experimental Psychology, University of Oxford, Oxford, UK; Department of Psychology, Institute of Psychiatry, King's College London, London, UK
| |
Collapse
|
24
|
Jiang J, He Z, Peng Y, Jin W, Mu J, Xue H, Wang Z, Chang M, Wang R. Effects of Phoenixin-14 on anxiolytic-like behavior in mice. Behav Brain Res 2015; 286:39-48. [DOI: 10.1016/j.bbr.2015.02.011] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2014] [Revised: 01/31/2015] [Accepted: 02/05/2015] [Indexed: 01/21/2023]
|
25
|
Neuroimaging in social anxiety disorder—A meta-analytic review resulting in a new neurofunctional model. Neurosci Biobehav Rev 2014; 47:260-80. [PMID: 25124509 DOI: 10.1016/j.neubiorev.2014.08.003] [Citation(s) in RCA: 256] [Impact Index Per Article: 25.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2014] [Revised: 06/26/2014] [Accepted: 08/01/2014] [Indexed: 01/30/2023]
|
26
|
Happé F, Frith U. Annual research review: Towards a developmental neuroscience of atypical social cognition. J Child Psychol Psychiatry 2014; 55:553-7. [PMID: 24963529 DOI: 10.1111/jcpp.12162] [Citation(s) in RCA: 161] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
As a starting point for our review we use a developmental timeline, starting from birth and divided into major developmental epochs defined by key milestones of social cognition in typical development. For each epoch, we highlight those developmental disorders that diverge from the normal developmental pattern, what is known about these key milestones in the major disorders affecting social cognition, and any available research on the neural basis of these differences. We relate behavioural observations to four major networks of the social brain, that is, Amygdala, Mentalizing, Emotion and Mirror networks. We focus on those developmental disorders that are characterized primarily by social atypicality, such as autism spectrum disorder, social anxiety and a variety of genetically defined syndromes. The processes and aspects of social cognition we highlight are sketched in a putative network diagram, and include: agent identification, emotion processing and empathy, mental state attribution, self-processing and social hierarchy mapping involving social ‘policing’ and in-group/out-group categorization. Developmental disorders reveal some dissociable deficits in different components of this map of social cognition. This broad review across disorders, ages and aspects of social cognition leads us to some key questions: How can we best distinguish primary from secondary social disorders? Is social cognition especially vulnerable to developmental disorder, or surprisingly robust? Are cascading notions of social development, in which early functions are essential stepping stones or building bricks for later abilities, necessarily correct?
Collapse
Affiliation(s)
- Francesca Happé
- MRC Social, Genetic and Developmental Psychiatry Centre Institute of Psychiatry King's College London London UK
| | - Uta Frith
- Institute of Cognitive Neuroscience University College London London UK
- Interacting Minds Centre Aarhus University Århus C Denmark
| |
Collapse
|
27
|
Plana I, Lavoie MA, Battaglia M, Achim AM. A meta-analysis and scoping review of social cognition performance in social phobia, posttraumatic stress disorder and other anxiety disorders. J Anxiety Disord 2014; 28:169-77. [PMID: 24239443 DOI: 10.1016/j.janxdis.2013.09.005] [Citation(s) in RCA: 114] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2013] [Revised: 07/15/2013] [Accepted: 09/12/2013] [Indexed: 10/26/2022]
Abstract
Social cognition deficits are observed in a variety of psychiatric illnesses. However, data concerning anxiety disorders are sparse and difficult to interpret. This meta-analysis aims at determining if social cognition is affected in social phobia (SP) or posttraumatic stress disorder (PTSD) compared to non-clinical controls and the specificity of such deficits relatively to other anxiety disorders. The scoping review aims to identify research gaps in the field. Forty studies assessing mentalizing, emotion recognition, social perception/knowledge or attributional style in anxiety disorders were included, totalizing 1417 anxious patients and 1321 non-clinical controls. Results indicate distinct patterns of social cognition impairments: people with PTSD show deficits in mentalizing (effect size d = -1.13) and emotion recognition (d = -1.6) while other anxiety disorders including SP showed attributional biases (d = -0.53 to d = -1.15). The scoping review identified several under investigated domains of social cognition in anxiety disorders. Some recommendations are expressed for future studies to explore the full range of social cognition in anxiety disorders and allow direct comparisons between different disorders.
Collapse
Affiliation(s)
- India Plana
- Département de Psychiatrie et neurosciences, Faculté de médecine, Université Laval, Canada; Centre de recherche de l'Institut universitaire en santé mentale de Québec, Canada
| | - Marie-Audrey Lavoie
- Centre de recherche de l'Institut universitaire en santé mentale de Québec, Canada; École de psychologie, Université Laval, Canada
| | - Marco Battaglia
- Département de Psychiatrie et neurosciences, Faculté de médecine, Université Laval, Canada; Centre de recherche de l'Institut universitaire en santé mentale de Québec, Canada
| | - Amélie M Achim
- Département de Psychiatrie et neurosciences, Faculté de médecine, Université Laval, Canada; Centre de recherche de l'Institut universitaire en santé mentale de Québec, Canada.
| |
Collapse
|
28
|
Jarcho JM, Leibenluft E, Walker OL, Fox NA, Pine DS, Nelson EE. Neuroimaging studies of pediatric social anxiety: paradigms, pitfalls and a new direction for investigating the neural mechanisms. BIOLOGY OF MOOD & ANXIETY DISORDERS 2013; 3:14. [PMID: 23849682 PMCID: PMC3733938 DOI: 10.1186/2045-5380-3-14] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/20/2013] [Accepted: 05/24/2013] [Indexed: 01/04/2023]
Abstract
Social Anxiety Disorder (SAD) is a common and debilitating condition that typically manifests in adolescence. Here we describe cognitive factors engaged by brain-imaging tasks, which model the peer-based social interactions that evoke symptoms of SAD. We then present preliminary results from the Virtual School paradigm, a novel peer-based social interaction task. This paradigm is designed to investigate the neural mechanisms mediating individual differences in social response flexibility and in participants' responses to uncertainty in social contexts. We discuss the utility of this new paradigm for research on brain function and developmental psychopathology.
Collapse
Affiliation(s)
- Johanna M Jarcho
- Section on Developmental and Affective Neuroscience, National Institute of Mental Health, National Institutes of Health, 9000 Rockville Pike, Building 15 K, Bethesda, MD 20892, USA
| | - Ellen Leibenluft
- Section on Bipolar Spectrum Disorders, National Institute of Mental Health, Bethesda, MD 20892, USA
| | - Olga Lydia Walker
- Department of Human Development, University of Maryland, College Park, MD 20742, USA
| | - Nathan A Fox
- Department of Human Development, University of Maryland, College Park, MD 20742, USA
- Department of Quantitative Methodology, University of Maryland, College Park, MD 20742, USA
| | - Daniel S Pine
- Section on Developmental and Affective Neuroscience, National Institute of Mental Health, National Institutes of Health, 9000 Rockville Pike, Building 15 K, Bethesda, MD 20892, USA
| | - Eric E Nelson
- Section on Developmental and Affective Neuroscience, National Institute of Mental Health, National Institutes of Health, 9000 Rockville Pike, Building 15 K, Bethesda, MD 20892, USA
| |
Collapse
|
29
|
Carré A, Gierski F, Lemogne C, Tran E, Raucher-Chéné D, Béra-Potelle C, Portefaix C, Kaladjian A, Pierot L, Besche-Richard C, Limosin F. Linear association between social anxiety symptoms and neural activations to angry faces: from subclinical to clinical levels. Soc Cogn Affect Neurosci 2013; 9:880-6. [PMID: 23651705 DOI: 10.1093/scan/nst061] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Social anxiety disorder (SAD), which is characterized by the fear of being rejected and negatively evaluated, involves altered brain activation during the processing of negative emotions in a social context. Although associated temperament traits, such as shyness or behavioral inhibition, have been studied, there is still insufficient knowledge to support the dimensional approach, which assumes a continuum from subclinical to clinical levels of social anxiety symptoms. This study used functional magnetic resonance imaging (fMRI) to examine the neural bases of individual differences in social anxiety. Our sample included participants with both healthy/subclinical as well as clinical levels of social anxiety. Forty-six participants with a wide range of social anxiety levels performed a gender decision task with emotional facial expressions during fMRI scanning. Activation in the left anterior insula and right lateral prefrontal cortex in response to angry faces was positively correlated with the level of social anxiety in a regression analysis. The results substantiate, with a dimensional approach, those obtained in previous studies that involved SAD patients or healthy and subclinical participants. It may help to refine further therapeutic strategies based on markers of social anxiety.
Collapse
Affiliation(s)
- Arnaud Carré
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Fabien Gierski
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Cédric Lemogne
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Eric Tran
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, France
| | - Delphine Raucher-Chéné
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Céline Béra-Potelle
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, France
| | - Christophe Portefaix
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Arthur Kaladjian
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Laurent Pierot
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, France
| | - Chrystel Besche-Richard
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| | - Frédéric Limosin
- Laboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Pôle de Psychiatrie Adulte, 51100 Reims, France, Université Paris Descartes, Sorbonne Paris 10 Cité, Faculté de Médecine, 75006 Paris, France, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Hôpitaux Universitaires Paris Ouest, 92130 Issy-Les-Moulineaux, Paris, France, INSERM U894, Centre de Psychiatrie et Neurosciences, 75014 Paris, France, Laboratoire CReSTIC (EA 3804), Université de Reims Champagne-Ardenne, 51100 Reims, France, and Institut Universitaire de France, 75005 Paris, FranceLaboratoire C2S (EA6291), Université de Reims Champagne-Ardenne, 51100 Reims, France, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, Pôle Imagerie, 51100 Reims, France, SFR CAP-Santé (FED 4231
| |
Collapse
|
30
|
Wiggins JL, Swartz JR, Martin DM, Lord C, Monk CS. Serotonin transporter genotype impacts amygdala habituation in youth with autism spectrum disorders. Soc Cogn Affect Neurosci 2013; 9:832-8. [PMID: 23526151 DOI: 10.1093/scan/nst039] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Failure of the amygdala to habituate, or decrease response intensity, to repeatedly presented faces may be one mechanism by which individuals with autism spectrum disorders (ASD) develop and maintain social symptoms. However, genetic influences on habituation in ASD have not been examined. We hypothesized that serotonin transporter-linked promoter region (5-HTTLPR) genotype affects change in amygdala response to repeated sad faces differently in individuals with ASD vs healthy controls. Forty-four youth with ASD and 65 controls aged 8-19 years were genotyped and underwent an event-related functional magnetic resonance imaging scan where they identified the gender of emotional faces presented for 250 ms. The first half of the run was compared with the second half to assess habituation. 5-HTTLPR genotype influences amygdala habituation to sad faces differently for individuals with ASD vs controls. The genotype-by-diagnosis-by-run half interaction was driven by individuals with ASD and low expressing genotypes (S/S, S/L(G) and L(G)/L(G)), who trended toward sensitization (increase in amygdala activation) and whose habituation scores significantly differed from individuals with ASD and higher expressing genotypes (L(A)/L(A), S/L(A) and L(A)/L(G)) as well as controls with low expressing genotypes. Our results show that amygdala response to social stimuli in ASD, which may contribute to social symptoms, is genetically influenced.
Collapse
Affiliation(s)
- Jillian Lee Wiggins
- Department of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA
| | - Johnna R Swartz
- Department of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA
| | - Donna M Martin
- Department of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USADepartment of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USADepartment of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA
| | - Catherine Lord
- Department of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA
| | - Christopher S Monk
- Department of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USADepartment of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USADepartment of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USADepartment of Psychology, Department of Pediatrics, Neuroscience Program, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA, and Department of Psychiatry and Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
31
|
Wiggins JL, Bedoyan JK, Carrasco M, Swartz JR, Martin DM, Monk CS. Age-related effect of serotonin transporter genotype on amygdala and prefrontal cortex function in adolescence. Hum Brain Mapp 2012; 35:646-58. [PMID: 23124623 DOI: 10.1002/hbm.22208] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2012] [Revised: 08/28/2012] [Accepted: 09/10/2012] [Indexed: 12/16/2022] Open
Abstract
The S and LG alleles of the serotonin transporter-linked polymorphic region (5-HTTLPR) lower serotonin transporter expression. These low-expressing alleles are linked to increased risk for depression and brain activation patterns found in depression (increased amygdala activation and decreased amygdala-prefrontal cortex connectivity). Paradoxically, serotonin transporter blockade relieves depression symptoms. Rodent models suggest that decreased serotonin transporter in early life produces depression that emerges in adolescence, whereas decreased serotonin transporter that occurs later in development ameliorates depression. However, no brain imaging research has yet investigated the moderating influence of human development on the link between 5-HTTLPR and effect-related brain function. We investigated the age-related effect of 5-HTTLPR on amygdala activation and amygdala-prefrontal cortex connectivity using a well-replicated probe, an emotional face task, in children and adolescents aged 9-19 years. A significant genotype-by-age interaction predicted amygdala activation, such that the low-expressing genotype (S/S and S/LG ) group showed a greater increase in amygdala activation with age compared to the higher expressing (LA /LA and S/LA ) group. Additionally, compared to the higher expressing group, the low-expressing genotype group exhibited decreased connectivity between the right amygdala and ventromedial prefrontal cortex with age. Findings indicate that low-expressing genotypes may not result in the corticolimbic profile associated with depression risk until later adolescence.
Collapse
|
32
|
Taddei M, Tettamanti M, Zanoni A, Cappa S, Battaglia M. Brain white matter organisation in adolescence is related to childhood cerebral responses to facial expressions and harm avoidance. Neuroimage 2012; 61:1394-401. [DOI: 10.1016/j.neuroimage.2012.03.062] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2011] [Revised: 03/19/2012] [Accepted: 03/20/2012] [Indexed: 01/23/2023] Open
|